Lanzhou Foci Pharmaceutical Co., Ltd.

The company is a “Chinese time-honored brand” enterprise with nearly 100 years of pharmaceutical history. It was first listed on the Shenzhen Stock Exchange in 2011. The company has 6 wholly-owned subsidiaries, 1 holding subsidiary, and 2 participating subsidiaries. Currently, there are 467 drug production approval numbers, and the pharmaceutical production line has passed the national drug GMP certification, the Australian TGA organization, and the Japanese Ministry of Health, Labor, and Welfare GMP certification. We produce concentrated pills, honey pills, granules, capsules, tablets, gels, etc. all year round. The company's industry is Chinese medicine manufacturing. Its main business is R&D, production and sales of proprietary Chinese medicines and health products, cultivation and sales of Chinese herbal medicines, processing and sales of Chinese herbal medicines, processing and sales of medical devices such as protective masks. The main products produced and sold by the company are Liuwei Dihuang Pills, Xiaoyao Pills, Fragrant Sand Nourishing Pills, Proprietary Chinese Medicines such as Ejiao, as well as traditional Chinese medicine tablets and health products, covering various categories and fields such as supplements, colds, gastroenterology, gynecology, and restful sleep. The company's main honors include: Key High-tech Enterprises under the National Torch Program; China's famous trademark, Buddha Ci; China's first batch of “Chinese Time-honored Brands”; 2012 Gansu Province's Top 100 Non-public Economic Tax Paying Enterprises; and the 2011 Governor's Finance Award.